Cytek Biosciences
CTKB
CTKB
160 hedge funds and large institutions have $311M invested in Cytek Biosciences in 2025 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 50 increasing their positions, 65 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
38% less capital invested
Capital invested by funds: $501M → $311M (-$191M)
91% less call options, than puts
Call options by funds: $2K | Put options by funds: $22K
Holders
160
Holding in Top 10
–
Calls
$2K
Puts
$22K
Top Buyers
| 1 | +$6.4M | |
| 2 | +$5.3M | |
| 3 | +$4.38M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$3.67M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.7M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$9.85M | |
| 3 | -$4.06M | |
| 4 |
BlackRock
New York
|
-$2.14M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.93M |